Sunday, 27 April 2025
  
Login

Australia's most trusted
source of pharma news

Sunday, 27 April 2025
News

Introducing the giants of the PBS

Posted 8 April 2025 AM

Less than a dozen mega-drugs accounted for more than half of the increase in PBS spending in calendar year 2024, analysis by Pharma in Focus has revealed.

Government spending on the R/PBS, pre-rebate, increased by $1.709 billion in 2024 compared to 2023, reaching $18.804 billion for the year. Eleven drugs saw their pre-rebate earnings increase by more than $50 million over that time frame, adding a cumulative $932.5 million to the bottom line of the scheme.

To see the whole article, please login

Popular

Biologics to double COPD market
Who's spending the most on HCPs?
Top earning CEO crown goes to...
PBS could become a 'brutal jungle'
Latest Jobs
MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.


Subscribe
 
© 2003 - 2025 Lush Media | Privacy Statement | Subscribe to Pharma in Focus
home